Illustrative image – not actual.Jubilant Organosys, a pharmaceutical and life sciences company on 30 August 2010 signed a research and manufacturing contract with a US based life sciences company.
Jubilant has not disclosed the name of the US based firm with whom it has signed a $33 million (approx Rs 155 crore) deal in research and manufacturing services (CRAMS) segment. The contract is for the initial term of four and a half years with the effect from August 2010.
The product under the pact is based on the in-house technology, integrated with captively produced raw materials resulting in competitive advantage both in terms of cost of production and capital investment.
